Lingua:
Valuta:
0 ARTICOLI - $0.00 Bonus: 2
Generic Videx EC (Didanosine)
Videx EC
Videx EC is an oral antiretroviral medication used to treat HIV-1 infection by inhibiting viral replication and helping to reduce viral load in the body.
Scegli I Dosaggi: 400mg
400mg
30pillole
Videx EC $453.59
$377.99
$12.60 a pillola
+ Free trackable courier service
+ Assicurazione per la spedizione
+ futuro ordine 10% di sconto
Aggiungi al carrello
salva: $0.00
400mg
60pillole
Videx EC $712.79
$593.99
$9.90 a pillola
+ Free trackable courier service
+ Assicurazione per la spedizione
+ futuro ordine 10% di sconto
Aggiungi al carrello
salva: $162.00
400mg
90pillole
Videx EC $1036.79
$863.99
$9.60 a pillola
+ Free trackable courier service
+ Assicurazione per la spedizione
+ futuro ordine 10% di sconto
Aggiungi al carrello
salva: $270.00
Package Example
Il tuo ordine sarà confezionato in maniera sicura e protetta e consegnato entro 24 ore. Ecco come la confezione apparirà (immagini reali dell'articolo inviato). Ha la dimensione e l'aspetto di una lettera comune (9.4x4.3x0.3 inches or 24x11x0.7cm) e non lascia trasparire il suo contenuto.
Ora di consegna
Consegna 14-21 giorni 10$ Tracking# disponibile in 4 giorni
Standart servizio gratuito di posta aerea per tutti gli ordini con importo a partire da $200
Consegna 5-9 giorni 30$ Tracking# disponibile in 2 giorni
Servizio di corriere gratuito di posta aerea per tutti gli ordini con importo a partire da $300
Spedizione internazionale Garanzia di riservatezza e anonimato
Sicurezza e protezione Discreet looking packages
Consegna ordini entro 24 ore Spedizione assicurata al 100%
Testimonianze Descrizione Del Prodotto
Al momento non ci sono recensioni per questo prodotto, ma tu potresti essere il primo a scriverne una, oppure puoi leggere la Pagina delle Recensioni su prodotti simili .

Aggiungi Commento

Common use

Videx EC (didanosine) is prescribed for the treatment of HIV-1 infection, usually in combination with other antiretroviral medications. It works as a nucleoside reverse transcriptase inhibitor (NRTI), blocking the action of reverse transcriptase, an enzyme critical for HIV replication, thereby slowing the progression of the infection.

Dosage and direction

Videx EC is taken orally, usually once daily on an empty stomach, either one hour before or two hours after meals. Swallow tablets or capsules whole; do not crush or chew. Dosage is based on body weight, age, kidney function, and other medications.

Precautions

Inform your doctor if you have pancreatitis, liver disease, kidney problems, diabetes, or a history of lactic acidosis. Regular monitoring of blood counts, liver, and kidney function is recommended. Avoid alcohol, as it may increase the risk of liver toxicity.

Contraindications

Do not use Videx EC if allergic to didanosine or any component of the formulation. It is contraindicated in patients with a history of pancreatitis related to didanosine.

Possible side effect

Common side effects include nausea, vomiting, diarrhea, abdominal pain, headache, and fatigue. Serious side effects may include pancreatitis, lactic acidosis, liver problems, peripheral neuropathy, or severe allergic reactions. Seek medical attention if severe symptoms occur.

Drug interaction

Videx EC may interact with allopurinol, ganciclovir, stavudine, or other medications affecting liver or kidney function. Inform your doctor about all prescription drugs, over-the-counter products, and supplements you are taking.

Missed dose

If a dose is missed, take it as soon as you remember, but do not take extra doses to make up for a missed one. Continue with your regular schedule.

Overdose

Overdose may cause severe nausea, vomiting, diarrhea, lactic acidosis, or pancreatitis. Seek immediate medical attention if overdose is suspected.

Storage

Store Videx EC at room temperature, away from moisture, heat, and light. Keep the medication in its original container and out of reach of children.

Common use

Videx EC (didanosine) is prescribed for the treatment of HIV-1 infection, usually in combination with other antiretroviral medications. It works as a nucleoside reverse transcriptase inhibitor (NRTI), blocking the action of reverse transcriptase, an enzyme critical for HIV replication, thereby slowing the progression of the infection.

Dosage and direction

Videx EC is taken orally, usually once daily on an empty stomach, either one hour before or two hours after meals. Swallow tablets or capsules whole; do not crush or chew. Dosage is based on body weight, age, kidney function, and other medications.

Precautions

Inform your doctor if you have pancreatitis, liver disease, kidney problems, diabetes, or a history of lactic acidosis. Regular monitoring of blood counts, liver, and kidney function is recommended. Avoid alcohol, as it may increase the risk of liver toxicity.

Contraindications

Do not use Videx EC if allergic to didanosine or any component of the formulation. It is contraindicated in patients with a history of pancreatitis related to didanosine.

Possible side effect

Common side effects include nausea, vomiting, diarrhea, abdominal pain, headache, and fatigue. Serious side effects may include pancreatitis, lactic acidosis, liver problems, peripheral neuropathy, or severe allergic reactions. Seek medical attention if severe symptoms occur.

Drug interaction

Videx EC may interact with allopurinol, ganciclovir, stavudine, or other medications affecting liver or kidney function. Inform your doctor about all prescription drugs, over-the-counter products, and supplements you are taking.

Missed dose

If a dose is missed, take it as soon as you remember, but do not take extra doses to make up for a missed one. Continue with your regular schedule.

Overdose

Overdose may cause severe nausea, vomiting, diarrhea, lactic acidosis, or pancreatitis. Seek immediate medical attention if overdose is suspected.

Storage

Store Videx EC at room temperature, away from moisture, heat, and light. Keep the medication in its original container and out of reach of children.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Testimonianze
Jerry, 57 anni, Monaco
“Eravamo sul punto di divorziare quando ho deciso di provarlo. Anni e anni senza il piacere dell’orgasmo e della soddisfazione sessuale. Ciò potrebbe rovinare qualsiasi vita ma non la nostra. Il Viagra ha funzionato e tengo sempre la pillola a portata ...
Mike, Palermo
“Continuerò ad usare il Cialis. Sto bene nei miei 60 anni ed il vostro Cialis mi ha restituito ciò che avevo perso: le erezioni durature ed i piaceri della gioventù. L’ordine è arrivato nel giro di 5 giorni ed in perfette condizioni. Ho ricevuto il mio ...
Rafale Le Roy Ladurie, France
Ho ricevuto il prodotto e volevo cogliere l’occasione per ringraziarvi per l’eccellente servizio clienti. La vostra azienda cura tutte le situazioni con professionalità. Grazie tante per l’attenzione tempestiva e certamente farò altri ordini da voi in ...
Per saperne di più...

Opzione Di Spedizione

Transazione Sicura
News
Ebola risk raised to 'very high' in DR Congo
The head of the UN health agency says the risk in the wider region is "high", but it remains "low" at the global level.
UK scientists developing Ebola vaccine that could be ready for trials in months
The rare species of Ebola involved - known as Bundibugyo - kills around a third of those infected and has no proven vaccine yet.
The tragedy of the 'invisible killer' of the young
Bereaved families are calling for a national cardiac screening programme for over-14s
Riskiest skin cancer cases hit UK record high
The number of melanoma skin cancer cases has risen above 20,000 a year for the first time in the UK.